Ali, A., Courtney, D., Broadbent, L., Sharma, P., Bamford, C. G. G., Manzoor, S., . . . Power, U. F. (2025). Preclinical Screening Platform Identifies Azatadine‐Dimaleate as a Potent Repurposed Therapeutic Against SARS‐CoV‐2 Infection. Wiley. https://doi.org/10.1002/jmv.70713
Citazione stile Chigago Style (17a edizione)Ali, Ahlam, et al. Preclinical Screening Platform Identifies Azatadine‐Dimaleate as a Potent Repurposed Therapeutic Against SARS‐CoV‐2 Infection. Wiley, 2025. https://doi.org/10.1002/jmv.70713.
Citatione MLA (9a ed.)Ali, Ahlam, et al. Preclinical Screening Platform Identifies Azatadine‐Dimaleate as a Potent Repurposed Therapeutic Against SARS‐CoV‐2 Infection. Wiley, 2025. https://doi.org/10.1002/jmv.70713.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.